[ad_1]
Investors have been looking beyond Big Tech in recent trading, signaling a possible shift to a value focus
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...